Johnson & Johnson’s strategy to use bankruptcy to resolve its multibillion-dollar litigation over claims its talc products cause cancer was rejected by a federal appeals court on Monday, which dismissed a bankruptcy petition by its talc subsidiary.
Go and Vote: Issued in Public Interest
